Delayed contrast extravasation MRI: a new paradigm in neuro-oncology.
Authors: Zach L, Guez D, Last D, Daniels D, Grober Y, Nissim O, Hoffmann C, Nass D, Talianski A, Spiegelmann R, Tsarfaty G, Salomon S, Hadani M, Kanner A, Blumenthal DT, Bukstein F, Yalon M, Zauberman J, Roth J, Shoshan Y, Fridman E, Wygoda M, Limon D, Tzuk T, Cohen ZR, Mardor Y
IGF1 induces cell proliferation in human pituitary tumors - functional blockade of IGF1 receptor as a novel therapeutic approach in non-functioning tumors.
, Molecular and cellular endocrinology
Authors: Rubinfeld H, Kammer A, Cohen O, Gorshtein A, Cohen ZR, Hadani M, Werner H, Shimon I
Intraoperative magnetic resonance imaging for resection of intra-axial brain lesions: a decade of experience using low-field magnetic resonance imaging, polestar N-10, 20, 30 systems.
, World neurosurgery
Authors: Livne O, Harel R, Hadani M, Spiegelmann R, Feldman Z, Cohen ZR
Description of the vasospasm phenomena following perimesencephalic nonaneurysmal subarachnoid hemorrhage.
07 2014, BioMed research international
Authors: Prat D, Goren O, Bruk B, Bakon M, Hadani M, Harnof S
Brain biopsy in AIDS patients: diagnostic yield and treatment applications.
01 2014, AIDS research and therapy
Authors: Zibly Z, Levy I, Litchevski V, Nass D, Hofmann C, Barham J, Graves CA, Spiegelmann R, Hadani M, Cohen ZR
Simulation-based interpersonal communication skills training for neurosurgical residents.
01 2014, The Israel Medical Association journal : IMAJ
Authors: Harnof S, Hadani M, Ziv A, Berkenstadt H
Potential of magnetic resonance-guided focused ultrasound for intracranial hemorrhage: an in vitro feasibility study.
08 2014, International journal of stroke : official journal of the International Stroke Society
Authors: Harnof S, Hananel A, Zilby Z, Kulbatski I, Hadani M, Kassell N
Modern intraoperative imaging modalities for the vascular neurosurgeon treating intracerebral hemorrhage.
12 2013, Neurosurgical focus
Authors: Goren O, Monteith SJ, Hadani M, Bakon M, Harnof S
Heparanase is highly expressed and regulates proliferation in GH-secreting pituitary tumor cells.
02 2012, Endocrinology
Authors: Rubinfeld H, Cohen-Kaplan V, Nass D, Ilan N, Meisel S, Cohen ZR, Hadani M, Vlodavsky I, Shimon I
Development and design of low field compact intraoperative MRI for standard operating room.
02 2011, Acta neurochirurgica. Supplement
Authors: Hadani M
Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.
12 2009, Endocrine-related cancer
Authors: Gorshtein A, Rubinfeld H, Kendler E, Theodoropoulou M, Cerovac V, Stalla GK, Cohen ZR, Hadani M, Shimon I
Epidemiology of gliomas in Israel: a nationwide study.
02 2009, Neuroepidemiology
Authors: Sadetzki S, Zach L, Chetrit A, Nass D, Hoffmann C, Ram Z, Zaaroor M, Umansky F, Rappaport ZH, Cohen A, Wald U, Rothman S, Hadani M
Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
11 2008, Stroke; a journal of cerebral circulation
Authors: Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A,
Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.
07 2009, Molecular and cellular endocrinology
Authors: Padova H, Rubinfeld H, Hadani M, Cohen ZR, Nass D, Taylor JE, Culler MD, Shimon I
Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men.
03 2007, European journal of endocrinology / European Federation of Endocrine Societies
Authors: Shimon I, Benbassat C, Hadani M
Magnetic resonance imaging-guided, high-intensity focused ultrasound for brain tumor therapy.
12 2006, Neurosurgery
Authors: Ram Z, Cohen ZR, Harnof S, Tal S, Faibel M, Nass D, Maier SE, Hadani M, Mardor Y
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.
11 2006, Clinical endocrinology
Authors: Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A
Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
06 2006, The Journal of clinical endocrinology and metabolism
Authors: Rubinfeld H, Hadani M, Barkai G, Taylor JE, Culler MD, Shimon I
Nitric oxide stimulates growth hormone secretion from human fetal pituitaries and cultured pituitary adenomas.
03 2006, Endocrine
Authors: Rubinek T, Rubinfeld H, Hadani M, Barkai G, Shimon I
Moyamoya disease--diagnosis and treatment: indirect cerebral revascularization at the Sheba Medical Center.
11 2005, The Israel Medical Association journal : IMAJ
Authors: Nissim O, Bakon M, Ben Zeev B, Goshen E, Knoller N, Hadani M, Feldman Z
Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results.
11 2005, Journal of neurosurgery. Spine
Authors: Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R, Marder JB, Yoles E, Belkin M, Schwartz M, Hadani M
Symptomatic hyponatremia as a presenting sign of hypothalamic-pituitary disease: a syndrome of inappropriate secretion of antidiuretic hormone (SIADH)-like glucocorticosteroid responsive condition.
06 2005, Journal of endocrinological investigation
Authors: Olchovsky D, Ezra D, Vered I, Hadani M, Shimon I
In vivo multiparametric monitoring of brain functions under intracranial hypertension following mannitol administration.
05 2005, Neurological research
Authors: Barbiro-Michaely E, Mayevsky A, Knoller N, Hadani M
Wet SEM: a novel method for rapid diagnosis of brain tumors.
03 2005, Ultrastructural pathology
Authors: Barshack I, Polak-Charcon S, Behar V, Vainshtein A, Zik O, Ofek E, Hadani M, Kopolovic J, Nass D
Malignant bronchial carcinoid tumor metastatic to the pituitary in a thyroid carcinoma patient: successful treatment with surgery, radiotherapy and somatostatin analog.
04 2005, Pituitary
Authors: Shimon I, Hadani M, Nass D, Zwas ST
PTR-3173 (somatoprim), a novel somatostatin analog with affinity for somatostatin receptors 2, 4 and 5 is a potent inhibitor of human GH secretion.
04 2005, Journal of endocrinological investigation
Authors: Shimon I, Rubinek T, Hadani M, Alhadef N
Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells.
02 2005, European journal of endocrinology / European Federation of Endocrine Societies
Authors: Rubinfeld H, Hadani M, Taylor JE, Dong JZ, Comstock J, Shen Y, DeOliveira D, Datta R, Culler MD, Shimon I
Management of pituitary apoplexy: clinical experience with 40 patients.
05 2005, Acta neurochirurgica
Authors: Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M, Shimon I
Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.
04 2004, Journal of neurosurgery
Authors: Lidar Z, Mardor Y, Jonas T, Pfeffer R, Faibel M, Nass D, Hadani M, Ram Z